July 29, 2024
| Trial | GO44457 MORPHEUS-NEO HCC |
|---|---|
| Cancer Type | Gastrointestinal |
| Hospital(s) | Belfast City Hospital |
| Information | A Phase Ib/II, open-label, multicenter, randomized platform study evaluating the efficacy and safety of neoadjuvant immunotherapy combinations in patients with surgically resectable hepatoceullular carcinoma |